---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-018629"
form_type: "8-K"
ticker: "BKYI"
cik: "0001019034"
company_name: "BIO KEY INTERNATIONAL INC"
filed_at: "2023-06-27T23:59:59+00:00"
generated_at: "2026-06-13T15:56:53.916598+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# BIO-key amends securities purchase agreement, waives defaults with AJB Capital

## Summary
- Amends Dec 2022 agreement: repurchase of up to 272k commitment shares if principal paid by July 22, 2023; up to 214k if paid by Aug 21, 2023, each for $1.00.
- Waives events of default related to late filing of Q1 2023 Form 10-Q and failure to timely register shares; registration waiver expires July 30, 2023.
- Original $2.2M note and 700k commitment shares issued in December 2022; amendment adjusts repurchase rights based on principal payment timing.

## SEC filing metadata
- accession: 0001437749-23-018629
- form_type: 8-K
- ticker: BKYI
- cik: 0001019034
- company_name: BIO KEY INTERNATIONAL INC
- filed_at: 2023-06-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1019034/000143774923018629/0001437749-23-018629-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1019034/000143774923018629/bkyi20230626_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-018629
- JSON: https://secwatch.observer/filing/0001437749-23-018629.json
- Plain text: https://secwatch.observer/filing/0001437749-23-018629.txt

## Key facts
- Material Agreements
  BIO KEY INTERNATIONAL INC amended Waiver and Amendment No. 1 to Securities Purchase Agreement with AJB Capital Investments, LLC (effective 2023-06-22).
  - Action: amendment
  - Agreement: equity purchase
  - Counterparty: AJB Capital Investments, LLC
  - Effective: 2023-06-22
  source text: On June 22, 2023, BIO-key International, Inc. (the “Company,” “we” or “us”) entered into a Waiver and Amendment No. 1 to Securities Purchase Agreement (the “Amendment”) with AJB Capital Investments, LLC (the “Investor”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1019034/000143774923018629/0001437749-23-018629-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.